Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 10/20 | 0.78 |
| ▸ | THRA | P10827 | 8/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13614369 | 0.96 | THRB (0.86) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL13614376 | 0.94 | THRB (0.84) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL1401854 | 0.93 | THRB (0.91) | THRBTHRAMEN1KMT2AHPGD | |
| SCHEMBL823056 | 0.88 | THRB (0.83) | THRBTHRAMEN1KMT2AHPGD | |
| SCHEMBL11031162 | 0.88 | THRB (1.00) | THRBTHRAMEN1KMT2AHPGD | |
| SCHEMBL74263 | 0.87 | THRB (0.76) | THRBTHRAMEN1KMT2AHPGD | |
| SCHEMBL6931228 | 0.87 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL2289080 | 0.87 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL4475071 | 0.87 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL28432245 | 0.87 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7618690-B2 | Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element | ASAHI GLASS COMPANY, LIMITED (JP) | 2009-11-17 | — | — | US | disclosed |
| US-7442418-B2 | Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element | ASAHI GLASS COMPANY, LIMITED (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20080204650-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL AND OPTICAL ELEMENT | ASAHI GLASS COMPANY LIMITED (JP) | 2008-08-28 | — | — | US | disclosed |
| US-7371438-B2 | Polymerizable liquid crystal compound, liquid crystal composition and optical anisotropic material | ASAHI GLASS COMPANY, LIMITED (JP) | 2008-05-13 | — | — | US | disclosed |
| US-20070102669-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND OPTICAL ANISOTROPIC MATERIAL | ASAHI GLASS COMPANY, LIMITED (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070104894-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL AND OPTICAL ELEMENT | ASAHI GLASS CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080204650-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL AND OPTICAL ELEMENT | CCNE2, CCNE1, CCNL2 | THRB 1589/4885THRA 1026/4885MEN1 2225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.